Annual Accounts Receivable
$71.00 K
-$177.00 K-71.37%
December 31, 2023
Summary
- As of February 7, 2025, BTAI annual accounts receivable is $71.00 thousand, with the most recent change of -$177.00 thousand (-71.37%) on December 31, 2023.
- BTAI annual accounts receivable is now -76.68% below its all-time high of $304.50 thousand, reached on July 1, 2014.
Performance
BTAI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$3000.00
-$809.00 K-99.63%
September 30, 2024
Summary
- As of February 7, 2025, BTAI quarterly accounts receivable is $3000.00, with the most recent change of -$809.00 thousand (-99.63%) on September 30, 2024.
- Over the past year, BTAI quarterly accounts receivable has dropped by -$68.00 thousand (-95.77%).
- BTAI quarterly accounts receivable is now -99.63% below its all-time high of $812.00 thousand, reached on June 30, 2024.
Performance
BTAI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
BTAI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.4% | -95.8% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
BTAI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.4% | -100.0% | -99.6% | -100.0% |
| 5 y | 5-year | -71.4% | -100.0% | -99.6% | -100.0% |
| alltime | all time | -76.7% | -100.0% | -99.6% | -100.0% |
BioXcel Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3000.00(-99.6%) |
| Jun 2024 | - | $812.00 K(+114.8%) |
| Mar 2024 | - | $378.00 K(+432.4%) |
| Dec 2023 | $71.00 K | $71.00 K(-90.3%) |
| Sep 2023 | - | $735.00 K(+70.5%) |
| Jun 2023 | - | $431.00 K(+52.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $283.00 K(+14.1%) |
| Dec 2022 | $248.00 K(>+9900.0%) | $248.00 K(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00 |
| Jul 2016 | $245.90 K(+38.1%) | - |
| Jul 2015 | $178.00 K(-41.5%) | - |
| Jul 2014 | $304.50 K | - |
FAQ
- What is BioXcel Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual accounts receivable year-on-year change?
- What is BioXcel Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly accounts receivable year-on-year change?
What is BioXcel Therapeutics annual accounts receivable?
The current annual accounts receivable of BTAI is $71.00 K
What is the all time high annual accounts receivable for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual accounts receivable is $304.50 K
What is BioXcel Therapeutics annual accounts receivable year-on-year change?
Over the past year, BTAI annual accounts receivable has changed by -$177.00 K (-71.37%)
What is BioXcel Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of BTAI is $3000.00
What is the all time high quarterly accounts receivable for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly accounts receivable is $812.00 K
What is BioXcel Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, BTAI quarterly accounts receivable has changed by -$68.00 K (-95.77%)